Treatment of CMV infection in renal transplant recipients with an abbreviated course of IV ganciclovir.

被引：0
|
作者：
Slavcheva, E
Jaffers, G
Narayanan, M
Moore, C
McCuskey, C
Carpenter, J
机构：
[1] Scott & White Mem Hosp & Clin, TAMU, Temple, TX 76508 USA
[2] Scott & White Mem Hosp & Clin, Div Nephrol, Temple, TX 76508 USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2002年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：564A / 564A
页数：1
相关论文
共 50 条
  • [41] DHPG TREATMENT OF KIDNEY-TRANSPLANT RECIPIENTS WITH SEVERE CMV INFECTION
    LANG, P
    BUISSON, C
    ROSTOKER, G
    BENMAADI, A
    FRUCHAUD, G
    DEFORGE, L
    CHOPIN, D
    ABBOU, C
    ROMANO, P
    FLEURY, J
    ESCUDIER, E
    BELGHITI, D
    ONCEVSKI, A
    DUVAL, J
    WEIL, B
    TRANSPLANTATION PROCEEDINGS, 1989, 21 (01) : 2084 - 2086
  • [42] CMV PRIMARY INFECTION AND SPECIFIC IGM RESPONSE IN RENAL-TRANSPLANT RECIPIENTS
    DEVILLECHABROLLE, A
    TUONG, NT
    LUCIANI, J
    FRANTZ, P
    HURAUX, JM
    PATHOLOGIE BIOLOGIE, 1987, 35 (08): : 1123 - 1126
  • [43] HLA Alleles Add to Risk Stratification for CMV Infection in Renal Transplant Recipients
    Patil, R.
    Prashar, R.
    Ramesh, M.
    Patel, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 772 - 773
  • [44] Comparison of Three Cellular Assays to Predict the Course of CMV Infection in Liver Transplant Recipients
    Gliga, Smaranda
    Fiedler, Melanie
    Dornieden, Theresa
    Achterfeld, Anne
    Paul, Andreas
    Horn, Peter A.
    Herzer, Kerstin
    Lindemann, Monika
    VACCINES, 2021, 9 (02) : 1 - 15
  • [45] CMV INFECTION IN HEART-TRANSPLANT RECIPIENTS
    THOMPSON, KS
    PLAPP, FV
    LONG, ND
    HEENAN, TA
    TRANSFUSION, 1992, 32 (08) : S65 - S65
  • [46] Clinical course of cytomegalovirus (CMV) viremia with and without ganciclovir treatment in CMV-seropositive kidney transplant recipients - Longitudinal follow-up of CMV pp65 antigenemia assay
    Yang, CW
    Kim, YO
    Kim, YS
    Kim, SY
    Moon, IS
    Ahn, HJ
    Koh, YB
    Bang, BK
    AMERICAN JOURNAL OF NEPHROLOGY, 1998, 18 (05) : 373 - 378
  • [47] Recurrent CMV disease after ganciclovir treatment in kidney and kidney-pancreas transplant recipients.
    Humar, A
    Uknis, M
    CarloneJambor, C
    Gillingham, K
    Dunn, D
    Matas, A
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A3319 - A3319
  • [48] Does valgan (ganciclovir hydrochloride) provide effective prophylaxis against cytomegaloviral (CMV) infection in liver transplant recipients?
    Jain, A
    Orloff, M
    Lansing, K
    Kashyap, R
    Mark, K
    Betts, R
    Menegus, M
    Bozorgzadeh, A
    JOURNAL OF HEPATOLOGY, 2004, 40 : 48 - 48
  • [49] Valgan (ganciclovir hydrochloride) provides ineffective prophylaxis against cytomegaloviral (CMV) infection in liver transplant recipients.
    Jain, A
    Orloff, M
    Lansing, K
    Kashyap, R
    Kelley, M
    Betts, R
    Menegus, M
    Adel, B
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 569 - 569
  • [50] TREATMENT OF RENAL TRANSPLANT-ASSOCIATED CYTOMEGALOVIRUS-INFECTION WITH GANCICLOVIR
    NICHOLSON, ML
    VEITCH, PS
    DONNELLY, PK
    FLOWER, AJE
    BELL, PRF
    TRANSPLANTATION PROCEEDINGS, 1990, 22 (04) : 1811 - 1812
12345